Can Colonoscopy Prep Cause Irregular Heartbeat?

Colonoscopy prep can trigger irregular heartbeats, and the mechanism is straightforward: the aggressive fluid loss caused by bowel-cleansing solutions shifts your body’s electrolyte balance, and your heart is exquisitely sensitive to those shifts. A population-based study found the risk of atrial fibrillation roughly tripled in the week following bowel preparation compared to control periods. For most healthy people the risk remains low in absolute terms, but for anyone with existing heart conditions or on certain medications, the connection deserves serious attention.

Why Bowel Prep Affects Your Heart

The laxative solutions used before a colonoscopy work by pulling large volumes of water into the intestines to flush them clean. This process doesn’t just remove stool; it strips away electrolytes dissolved in that fluid. Potassium, magnesium, sodium, and phosphorus levels can all swing during and after prep. Your heart’s electrical system depends on precise concentrations of these minerals to maintain its rhythm. When potassium drops too low, for instance, the heart’s cells become more excitable and prone to firing out of sequence. Magnesium depletion compounds the problem because magnesium helps stabilize the electrical channels that potassium flows through.

A study measuring heart rate variability before and after bowel preparation found that prep was associated with significantly reduced variability across multiple measures of cardiac autonomic function. The researchers noted higher phosphorus and lower potassium levels in the prep group and concluded that the electrolyte imbalance likely drove the changes in heart rhythm regulation.¹ Reduced heart rate variability is a recognized marker of cardiac vulnerability, meaning the heart becomes less adaptable to changing demands and more susceptible to rhythm disturbances.

Dehydration itself also plays a role. Losing liters of fluid over several hours reduces blood volume, which can lower blood pressure and trigger the body’s stress-response systems. The sympathetic nervous system ramps up to compensate, increasing heart rate and potentially setting the stage for skipped beats or racing episodes. In someone whose heart is already electrically fragile, this combination of electrolyte depletion and volume loss can be enough to provoke a clinically significant arrhythmia.

Bowel Prep and Atrial Fibrillation

The most studied connection between colonoscopy prep and heart rhythm problems involves atrial fibrillation, the most common sustained arrhythmia in adults. A population-based case-crossover study examined whether bowel preparation was associated with new episodes of atrial fibrillation. The design compared each patient’s own exposure to prep during a “hazard” window before their arrhythmia diagnosis against earlier control periods, effectively letting each person serve as their own control.

The results were striking. In the one-week window after bowel preparation, the odds of developing atrial fibrillation were about three times higher than during control periods. That elevated risk persisted, though it gradually tapered: roughly threefold at two weeks, threefold at four weeks, and about two-and-a-half-fold at twelve weeks.² The fact that the association lingered for weeks suggests that bowel prep may unmask a susceptibility to atrial fibrillation rather than simply causing a one-time electrical glitch that resolves once fluids are replenished.

This doesn’t mean one in three people who do a colonoscopy prep will develop atrial fibrillation. The absolute risk remains small for most individuals. But for someone who already has risk factors for atrial fibrillation, such as older age, high blood pressure, obesity, or a history of heart valve disease, the prep may act as a trigger that tips them over the threshold.

Severe Arrhythmias Are Rare but Documented

Beyond atrial fibrillation, more dangerous rhythm disturbances have been reported in isolated cases. One case involved a 48-year-old woman who developed a life-threatening arrhythmia called Torsades de Pointes in the recovery area after an otherwise uneventful endoscopy. She had severe electrolyte derangements and an underlying long QT syndrome that the bowel prep appeared to unmask, leading to pulseless ventricular fibrillation requiring defibrillation.³ This is an extreme outcome, but it illustrates how electrolyte shifts from prep can interact with pre-existing cardiac vulnerabilities in unpredictable ways.

Cardiovascular adverse reactions to bowel prep solutions more broadly include low blood pressure, slow heart rate, and arrhythmias. A case report of a suspected heart attack after taking a polyethylene glycol preparation with ascorbic acid noted that while these cardiovascular side effects are recognized, actual myocardial infarction after prep is extraordinarily rare.⁴ The rarity is important context: tens of millions of colonoscopies are performed each year, and the vast majority proceed without cardiac complications. The risk exists, but it is not common.

Not All Prep Formulations Carry the Same Risk

Colonoscopy prep solutions come in several chemical families, and they differ in how aggressively they affect electrolytes. The two most commonly discussed categories are isotonic polyethylene glycol (PEG) solutions and hyperosmolar solutions like sodium phosphate or magnesium citrate-based preps.

PEG-based solutions (the large-volume drinks often sold under brand names like GoLYTELY or MiraLAX) are designed to pass through the gut without being absorbed much, theoretically causing fewer electrolyte shifts. A randomized trial comparing PEG with sodium phosphate found that the frequency of arrhythmias was similar across groups during the preparation period.⁵ Another prospective study using ambulatory heart monitors placed 24 hours before prep and removed after colonoscopy found no increase in premature ventricular contractions or other serious arrhythmias in either a sodium phosphate or a PEG group.⁶

Magnesium citrate-based preps raise a different concern: they can temporarily raise blood magnesium levels. One study specifically assessed cardiac conduction in patients receiving a sodium picosulfate and magnesium citrate prep and found no clinically meaningful changes in heart rhythm or QT interval prolongation, even among patients whose magnesium levels were elevated.⁷ That’s reassuring for patients with normal kidney function, but people with impaired kidneys may not be able to clear excess magnesium efficiently, raising the potential for problems.

Newer tablet-based preparations offer a lower-volume alternative for people who struggle to drink large quantities of fluid, but many of these are hyperosmolar. The American College of Gastroenterology has flagged that tablet preps could carry increased risk for patients with congestive heart failure, kidney problems, or existing electrolyte disturbances, and has called for more data in those groups.⁸

Older Adults and Patients With Heart Disease

Age is one of the strongest modifiers of cardiac risk from bowel prep. Older adults tend to have less physiological reserve to buffer electrolyte swings, they are more likely to take medications that affect electrolytes (like diuretics), and they have higher baseline rates of heart rhythm disorders. A large population-based study of more than 50,000 Ontario residents aged 66 and older found that serious events, a category that included cardiac events, occurred in about 2.4% of outpatient colonoscopy patients regardless of whether they received PEG or sodium phosphate prep. Among high-risk patients, the rate was about 2.8%.⁹

People with pre-existing heart disease face a compounded risk. Holter monitoring during elective colonoscopy has revealed a high incidence of new but silent ischemic and arrhythmic changes on ECG in patients with documented stable heart disease and, to a lesser degree, in those with cardiovascular risk factors alone.¹⁰ “Silent” is the key word: these patients had no symptoms but showed measurable electrical changes in the heart. That finding suggests the true rate of cardiac effects is higher than the rate of clinically recognized events, because many episodes go unnoticed.

Medications complicate matters further. Diuretics like furosemide or hydrochlorothiazide can already lower potassium and magnesium levels. Adding a bowel prep on top of chronic diuretic use can deepen those deficits. Some heart medications, including certain antiarrhythmics and some psychiatric drugs, prolong the QT interval on an ECG. When electrolyte drops from prep extend QT even further, the risk of dangerous arrhythmias like the Torsades de Pointes case described earlier increases substantially.

Vasovagal Reactions During Colonoscopy

A related but distinct cardiac event is the vasovagal reaction, which involves a sudden drop in heart rate and blood pressure. This happens not because of electrolyte shifts but because the vagus nerve is stimulated during the procedure, often by stretching or looping of the colon as the scope advances. A study of 223 colonoscopy patients found that about 16.5% experienced a vasovagal reaction, defined as a sustained heart rate below 60 beats per minute, a blood pressure drop, or both.¹¹

Vasovagal episodes feel alarming: you may become suddenly lightheaded, sweaty, pale, or briefly lose consciousness. But they are generally short-lived and respond well to stopping the procedure, administering fluids, and giving the nervous system time to recover. They are worth knowing about because patients sometimes confuse these episodes with heart attacks or dangerous arrhythmias. While uncomfortable and occasionally scary, vasovagal reactions during colonoscopy are almost always benign and self-correcting.

That said, someone who arrives at the procedure already dehydrated and electrolyte-depleted from an aggressive bowel prep may be more susceptible to a vasovagal reaction than someone in a better hydrated state. The prep and the procedure can interact: the prep weakens the body’s cardiovascular reserve, and the procedure applies a vagal stimulus that might have been tolerated easily under normal circumstances.

How to Reduce Your Cardiac Risk During Prep

The most important step is honest communication with your doctor about your full medical history before your colonoscopy is scheduled. If you have heart failure, kidney disease, a history of arrhythmia, or take diuretics or QT-prolonging medications, your gastroenterologist needs to know. This information affects which prep solution is safest for you and whether any electrolyte monitoring should happen before, during, or after the prep.

Hydration during prep matters enormously. The prep instructions typically include guidance to drink clear fluids beyond the prep solution itself. This isn’t optional padding; it’s a countermeasure against volume depletion. Sports drinks, broth, and clear juices help replenish some of the electrolytes being lost. Skipping these extra fluids or cutting them short because you feel too bloated to drink more is one of the most common ways patients inadvertently worsen their cardiac risk.

Split-dose prep regimens, where you drink half the solution the evening before and the other half the morning of the procedure, have become standard in many practices. Beyond improving the quality of the bowel cleanse, splitting the dose spreads the fluid and electrolyte shifts over a longer period, giving the body more time to compensate. If your doctor’s office still instructs you to drink the entire prep the night before, it is reasonable to ask about a split-dose option.

For higher-risk patients, some clinicians order blood work before and after prep to check potassium, magnesium, and kidney function. If levels are significantly off, the colonoscopy may be postponed until they are corrected. This is not standard practice for every patient, but for someone on chronic diuretics or with a history of low potassium, it can catch a dangerous drop before it causes a problem on the procedure table.

When to Seek Medical Attention

During or after your bowel prep, certain symptoms warrant a call to your doctor or a visit to urgent care rather than waiting for the procedure. Persistent heart palpitations that last more than a few seconds, a racing heartbeat that doesn’t settle with rest, chest pain or pressure, severe dizziness or fainting, and muscle cramps accompanied by weakness are all signs that your electrolytes may have shifted beyond what your body can easily handle. Severe vomiting during prep is another red flag, because it compounds fluid loss and may indicate that the prep solution itself is not being tolerated.

After the colonoscopy, the risk doesn’t vanish the moment you leave the facility. As the atrial fibrillation study showed, the elevated risk of arrhythmia persists for days to weeks.² If you develop a new irregular heartbeat, unexplained fatigue, or shortness of breath in the days following your colonoscopy, these symptoms deserve medical evaluation even if the procedure itself went smoothly. Most post-colonoscopy patients focus on watching for abdominal symptoms like bleeding or pain, but cardiac symptoms in the recovery window are equally worth paying attention to.

Why the Evidence Looks Contradictory

If you research this topic on your own, you may find studies that seem to flatly contradict each other. Some show no increase in arrhythmias during prep; others show a threefold increase in atrial fibrillation risk. The discrepancy mostly comes down to who was studied and how rhythm was monitored.

Studies that enrolled relatively young, healthy volunteers and monitored them with ambulatory ECGs during the prep period tended to find no meaningful increase in arrhythmias. The prospective comparison that placed 24-hour Holter monitors on outpatients found no bump in premature ventricular contractions during either sodium phosphate or PEG prep.⁶ But these studies typically excluded people with significant heart disease, the very patients most vulnerable to electrolyte-driven arrhythmias.

Meanwhile, the population-based study that found the threefold atrial fibrillation risk drew from a broad real-world patient population that included older and sicker people. And the Holter studies of patients with known stable heart disease found a high rate of silent ischemic and arrhythmic changes. The picture that emerges is consistent: for young, healthy patients, the cardiac risk of bowel prep is genuinely very low. For older patients or those with cardiovascular disease, the risk is real and measurable, even when the patient feels fine.

This is a common pattern in medicine. A procedure that is safe for most people carries meaningful risk for a subset, and studies that focus on the healthy majority will produce different conclusions than studies that focus on vulnerable populations. Neither set of findings is wrong; they just apply to different patients. If you have a healthy heart and normal kidney function, your bowel prep is unlikely to cause a rhythm disturbance. If you have heart disease, take medications that affect electrolytes, or have impaired kidney function, the prep warrants extra caution and possibly extra monitoring.